BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34818980)

  • 61. Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer.
    Li T; Guo H; Song Y; Zhao X; Shi Y; Lu Y; Hu S; Nie Y; Fan D; Wu K
    Mol Cancer; 2014 Dec; 13():263. PubMed ID: 25496021
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and migration of colorectal cancer cells through blocking transforming growth factor β signaling.
    Liu Z; Wang N; Wang F; Zhang S; Ding J
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693738
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
    Zhang Y; Li KF
    Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
    Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
    World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of fibroblast growth factor 4 in the growth and metastasis of colorectal cancer.
    Ye Y; Jiang D; Li J; Han C; Wang X; Wang F; Li J
    Int J Oncol; 2020 Jun; 56(6):1565-1573. PubMed ID: 32236572
    [TBL] [Abstract][Full Text] [Related]  

  • 66. YWHAG promotes colorectal cancer progression by regulating the CTTN-Wnt/β-catenin signaling axis.
    Wang Y; Cao Y; Chen Y; Cheng H; Liu Z; Wang M; Feng Y; Fei B; Cui K; Huang Z
    Med Oncol; 2024 Mar; 41(5):100. PubMed ID: 38538804
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer.
    He J; Huang H; Du Y; Peng D; Zhou Y; Li Y; Wang H; Zhou Y; Nie Y
    Cell Oncol (Dordr); 2020 Jun; 43(3):409-420. PubMed ID: 32166582
    [TBL] [Abstract][Full Text] [Related]  

  • 69. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
    Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
    Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
    [TBL] [Abstract][Full Text] [Related]  

  • 70. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Upregulated NTF4 in colorectal cancer promotes tumor development via regulating autophagy.
    Yang Z; Chen Y; Wei X; Wu D; Min Z; Quan Y
    Int J Oncol; 2020 Jun; 56(6):1442-1454. PubMed ID: 32236587
    [TBL] [Abstract][Full Text] [Related]  

  • 72. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
    Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
    Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
    [TBL] [Abstract][Full Text] [Related]  

  • 73. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
    Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
    Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
    [TBL] [Abstract][Full Text] [Related]  

  • 74. POTEE promotes colorectal carcinoma progression via activating the Rac1/Cdc42 pathway.
    Xu Q; Chen J; Peng M; Duan S; Hu Y; Guo D; Geng J; Zhou J
    Exp Cell Res; 2020 May; 390(1):111933. PubMed ID: 32142855
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
    Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
    Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
    [TBL] [Abstract][Full Text] [Related]  

  • 76. DEP Domain Containing 1 Promotes Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Colorectal Cancer by Enhancing Expression of Suppressor of Zest 12.
    Wang Q; Jiang S; Liu J; Ma G; Zheng J; Zhang Y
    Cancer Biother Radiopharm; 2021 Feb; 36(1):36-44. PubMed ID: 32343606
    [No Abstract]   [Full Text] [Related]  

  • 77. B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients.
    Yao Y; Ye H; Qi Z; Mo L; Yue Q; Baral A; Hoon DSB; Vera JC; Heiss JD; Chen CC; Zhang J; Jin K; Wang Y; Zang X; Mao Y; Zhou L
    Clin Cancer Res; 2016 Jun; 22(11):2778-2790. PubMed ID: 27001312
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human colorectal adenocarcinoma.
    Wang YP; Guo PT; Zhu Z; Zhang H; Xu Y; Chen YZ; Liu F; Ma SP
    Oncol Rep; 2017 Apr; 37(4):1961-1970. PubMed ID: 28259923
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 80. WNT4 secreted by tumor tissues promotes tumor progression in colorectal cancer by activation of the Wnt/β-catenin signalling pathway.
    Yang D; Li Q; Shang R; Yao L; Wu L; Zhang M; Zhang L; Xu M; Lu Z; Zhou J; Huang L; Huang X; Cheng D; Yang Y; Yu H
    J Exp Clin Cancer Res; 2020 Nov; 39(1):251. PubMed ID: 33222684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.